Biomedicines (Dec 2022)

Cytokine Profiles Differentiate Symptomatic from Asymptomatic PTSD in Service Members and Veterans with Chronic Traumatic Brain Injury

  • Ethan G. Smith,
  • James Hentig,
  • Carina Martin,
  • Chelsea Wagner,
  • Vivian A. Guedes,
  • Katie A. Edwards,
  • Christina Devoto,
  • Kerri Dunbar,
  • Michael J. Roy,
  • Jessica M. Gill

DOI
https://doi.org/10.3390/biomedicines10123289
Journal volume & issue
Vol. 10, no. 12
p. 3289

Abstract

Read online

Traumatic brain injuries (TBI) and posttraumatic stress disorder (PTSD) are commonly observed comorbid occurrences among military service members and veterans (SMVs). In this cross-sectional study, SMVs with a history of TBI were stratified into symptomatic and asymptomatic PTSD groups based on posttraumatic stress checklist-civilian (PCL-C) total scores. Blood-based biomarkers were assessed, and significant differential markers were associated with scores from multiple neurobehavioral self-report assessments. PCL-C cutoffs were total scores >50 (PTSD symptomatic) and p 0.624 for all, p p < 0.05, respectively). This is the first study focused on PTSD symptom severity to report levels of circulating pro-inflammatory IL8, specifically in SMVs with TBI. These data suggest that within the military TBI population, there are unique cytokine profiles that relate to neurobehavioral outcomes associated with TBI and PTSD.

Keywords